Precision. Accuracy. Integrity.

Founded in New Zealand in 2005, Izon Science took its name in 2008, focusing its mission on becoming a global leader at the intersection of nanotechnology and biology. Under the leadership of CEO and co-founder Hans van der Voorn, Izon grew its team, expertise and product range in nanoparticle separation and analysis.

Izon is the world leader in tunable resistive pulse sensing (TRPS), a measurement technology which enables nanoparticles to be analysed with an unmatched level of resolution. This capability provides critical insights into sample characteristics, advancing nanomedicine and a broad spectrum of biological research.

Also central to Izon’s portfolio is the qEV isolation platform, a highly versatile solution for nanoparticle purification based on size exclusion chromatography (SEC) qEV columns. The introduction of the Automatic Fraction Collector (AFC) in 2019 marked a major shift from labour-intensive manual collection to a rapid and reproducible method that can be scaled up for larger-scale studies.

Izon is a world leader in TRPS, a technology which enables nanoparticles to be analysed with an unmatched level of resolution. While TRPS was always part of the vision, Izon’s development of tools for nanoparticle isolation entered the scene later on. Since the first launch of the qEVoriginal in 2014, the range of Legacy columns has evolved to accommodate different sample loading volumes from 150 µL to 100 mL. qEV columns have since been used to analyse diverse sample types across a wide range of applications. The introduction of the Automatic Fraction Collector (AFC) in 2019 marked a major shift from labour-intensive manual collection to a rapid and reproducible method that can be scaled up for larger-scale biomarker studies.

Initially developed to enable efficienct sample purification for TRPS analysis, the qEV platform has become indispensable for laboratories and manufacturing facilities working with extracellular vesicles (EVs), with applications now extending beyond EVs.

Izon’s developments extend further, offering solutions such as liquid handling systems for high-throughput nanoparticle purification, customised qEV columns for industrial-scale processing, and automated chromatography units, including those designed for cGMP-compliant environments. These advancements reflect Izon’s commitment to delivering precise, scalable solutions for diagnostic and therapeutic applications worldwide.